Skip to main content

Table 2 Logistic regression analysis of glucose-related variables between plaque rupture and erosion

From: The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

Exposure

Statistics

Non-adjusted

Adjustment I

Adjustment II

HbA1c (%)

6.43 ± 1.44

1.19 (1.03, 1.36) 0.0153

1.13 (0.98, 1.30) 0.0915

1.12 (0.97, 1.30) 0.1264

ARPG (mmol/L)

9.30 ± 3.80

1.08 (1.03, 1.13) 0.0018

1.06 (1.01, 1.12) 0.0141

1.06 (1.01, 1.11) 0.0256

PFPG (mmol/L)

7.95 ± 3.56

1.03 (0.98, 1.08) 0.2441

1.01 (0.96, 1.06) 0.7984

1.01 (0.96, 1.06) 0.8090

A/C

1.25 ± 0.37

1.60 (0.94, 2.73) 0.0858

1.46 (0.85, 2.51) 0.1714

1.43 (0.83, 2.45) 0.1943

DM history

 No

634 (72.7%)

1

1

1

 Yes

238 (27.3%)

1.53 (1.06, 2.21) 0.0231

1.42 (0.96, 2.09) 0.0800

1.38 (0.92, 2.05) 0.1155

GVT

 Normal

49 (6.4%)

1

1

1

 Up

210 (27.5%)

2.83 (1.48, 5.39) 0.002

2.01 (1.02, 3.99) 0.045

2.03 (1.02, 4.07) 0.044

 Down

504 (66.1%)

2.83 (1.56, 5.14) 0.001

2.16 (1.15, 4.04) 0.016

2.04 (1.09, 3.85) 0.027

Strati-HbA1c

 < 6.5

471 (70.2%)

1

1

1

 ≥ 6.5

200 (29.8%)

1.18 (0.45, 3.12) 0.7393

1.29 (0.47, 3.54) 0.6234

1.34 (0.48, 3.76) 0.5778

Strati-ARPG

 < 6.1

117 (13.4%)

1

1

1

 ≥ 6.1, < 7.1

144 (16.5%)

1.41 (0.84, 2.37) 0.1909

1.25 (0.71, 2.20) 0.4396

1.17 (0.66, 2.08) 0.5945

 ≥ 7.1, < 11.1

412 (47.3%)

2.07 (1.32, 3.24) 0.0014

1.63 (1.00, 2.67) 0.0517

1.58 (0.96, 2.61) 0.0736

 ≥ 11.1

199 (22.8%)

2.29 (1.24, 4.21) 0.0080

2.05 (1.05, 3.99) 0.0345

1.99 (1.02, 3.90) 0.0438

Strati-PFPG

 < 5.6

204 (26.7%)

1

1

1

 ≥ 5.6, < 6.1

88 (11.5%)

0.92 (0.53, 1.60) 0.7804

0.81 (0.46, 1.44) 0.4826

0.87 (0.49, 1.56) 0.6417

 ≥ 6.1, < 7.0

112 (14.7%)

1.01 (0.61, 1.70) 0.9603

0.90 (0.52, 1.53) 0.6905

0.90 (0.52, 1.55) 0.7027

 ≥ 7.0

359 (47.1%)

1.37 (0.93, 2.04) 0.1145

1.10 (0.72, 1.67) 0.6527

1.14 (0.74, 1.74) 0.5611

  1. Data are presented as OR (95% CI) P value. Adjustment I for: age; gender; HTN history; current smoking; LDL-C. Adjustment II for: age; gender; HTN history; current smoking; LDL-C; initial TIMI flow; multivessel lesion, and culprit vessel
  2. A/C admission/chronic glycaemia ratio, ARPG admission random plasma glucose, DM diabetes mellitus, GVT glucose variable tendency, HbA1c glycosylated hemoglobin, HTN hypertension, LDL-C low density lipoprotein cholesterol, PCI percutaneous coronary intervention, PFPG post-PCI fasting plasma glucose, Strati- stratification, TIMI thrombolysis in myocardial infarction